Abstract:Endogenous neural stem cells (eNSCs) are a new therapeutic strategy for the noninvasive repair of spinal cord injury (SCI). Necroptosis is a necrosome-dependent cell death process that serves as a significant regulatory mechanism in SCI. Current research shows that neurons, oligodendrocytes, and astrocytes all undergo necroptosis after SCI. However, it is unclear whether eNSCs are associated with necroptosis after SCI. By performing immunofluorescence analysis, we found that eNSCs undergo necroptosis during spinal cord injury repair in mice. Our present work demonstrates that receptor-interacting protein kinase 1 (RIPK1)/mixed lineage kinase domain-like protein (MLKL) are involved in necroptosis pathway in SCI mice. In vitro, the necroptosis induced by TNF-α/Smac-mimetic/Z-VAD-FMK (TSZ) treatment regulates phenotype of NSCs. In detail, the proliferative capacity of NSCs was significantly decreased in the presence of continual TSZ treatment, and the transcription of proinflammatory genes was upregulated, while the transcription of neurotrophic factors was inhibited. NSCs exhibited an obvious tendency to differentiate into glial cells under short-duration TSZ stimulation (6 h and 12 h); as the stimulus duration increased (24 h), the differentiation ability of the NSCs was significantly inhibited. These phenotypic changes are not conducive to neural cell survival and neural repair. Moreover, we examined the effect of necroptosis inhibitors on TSZ-treated NSCs. Necrostatin-1 and necrosulfonamide significantly reduced the necroptosis of NSCs after TSZ treatment and improved the phenotypic function of NSCs under TSZ stimulation. In additional in vivo experiments, after 2 weeks of administration, the necroptosis inhibitors reduced the necroptosis of NSCs and improved functional recovery in SCI mice. Taken together, these data indicate that the inhibition of NSC necroptosis with necroptosis inhibitors facilitates survival and phenotype maintenance in vitro and contributes to neuroprotection and repair in vivo. Our findings suggest that blocking necroptosis of eNSCs may be a potential therapeutic strategy for treating SCI.

Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration

Mtor is Necessary for Proper Satellite Cell Activity and Skeletal Muscle Regeneration.

Stage-specific Effects of Notch Activation During Skeletal Myogenesis

Uncovering the Transcriptional Circuitry in Skeletal Muscle Regeneration

Deletion of TECRL Promotes Skeletal Muscle Repair by Up-Regulating EGR2

Tenascin-C from the tissue microenvironment promotes muscle stem cell self-renewal through Annexin A2

Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling

Temporal Single-Cell Sequencing Analysis Reveals That GPNMB-Expressing Macrophages Potentiate Muscle Regeneration

Tumor Necrosis Factor-Alpha Modulates Expression of Genes Involved in Cytokines and Chemokine Pathways in Proliferative Myoblast Cells

Necroptosis mediates myofibre death in dystrophin-deficient mice

CaMKK2 Suppresses Muscle Regeneration Through the Inhibition of Myoblast Proliferation and Differentiation

Nec-1 alleviated the deleterious effect of CoCl2 on C2C12 myoblast differentiation and fusion via the mTOR pathway

Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCI

Optineurin Promotes Myogenesis During Muscle Regeneration in Mice by Autophagic Degradation of GSK3β

Tumor Necrosis Factor Α Deficiency Promotes Myogenesis and Muscle Regeneration

Loss of Tob1 promotes muscle regeneration through muscle stem cell expansion

Tcf12 is Required to Sustain Myogenic Genes Synergism with MyoD by Remodelling the Chromatin Landscape

The Transcription Factor Mohawk Facilitates Skeletal Muscle Repair via Modulation of the Inflammatory Environment

Myogenic Regulatory Factors Transactivate the Tceal7 Gene and Modulate Muscle Differentiation.

Deletion of phosphatidylserine flippase β-subunit Tmem30a in satellite cells leads to delayed skeletal muscle regeneration

Skeletal Muscle Regeneration in Cardiotoxin-Induced Muscle Injury Models